Drug · CHEMBL615
PENICILLIN V
7 sourcespipelines-2026-09-18-0.3.1
Cite this record
ConductScience Library. PENICILLIN V. Drugs and targets, record CHEMBL615. Release pipelines-2026-09-18-0.3.1, 18 Sept 2026. https://conductscience.org/library/drugs/CHEMBL615
On this page
Drug
Names and IDs as ChEMBL gives them, through Open Targets.
- Other names
- Distaquaine v, Fenoximetilpenicilina, Penicillin phenoxymethyl, Phenomycilline, Phenoxymethylpenicillin, Phenoxymethylpenicilline, Phenoxymethylpenicillinum, Vebecillin
- ChEMBL
- Open Targets' highest stage
- Approval, for 7 of its 10 diseases, from ATC, DailyMed and TTD
- Open Targets
Targets0
The targets ChEMBL's mechanism records give for the drug, through Open Targets. A mechanism record says what the drug acts on, not how strongly.
None in this release.
Diseases10
The diseases Open Targets' clinical reports study the drug for, the most trial reports first. The stage is Open Targets', the highest any of its sources reports for the pair, and each row names the sources that report it.
Source Open Targets
Trials14
Trials whose record names the drug by a name ChEMBL states, posted results first, then the largest. Open Targets read each trial's text to find its drugs. 1 more that Open Targets linked to it is not shown, since the release's checks do not confirm it.
| Trial | Title | Phase | Participants | Results first posted | Named as | Linked by | Source |
|---|---|---|---|---|---|---|---|
| NCT05082909 | Addition of Probenecid to Penicillin-V Therapy | Phase 1/2 | 21 | 2025-01-30 | penicillin-V | Its name | ClinicalTrials.gov |
| NCT03847610 | Minimally Invasive Sensing of Beta-lactam Antibiotics | Phase 1 | 11 | 2020-12-29 | phenoxymethylpenicillin | Its name | ClinicalTrials.gov |
| NCT02712307 | Study of 5 and 10 Days Treatment With Penicillin Against Sore Throat Caused by Streptococci | Phase 4 | 433 | phenoxymethylpenicillin | Its name | ClinicalTrials.gov | |
| NCT02922686 | Penicillin for the Emergency Department Outpatient Treatment of CELLulitis | Phase 4 | 414 | phenoxymethylpenicillin | Its name | ClinicalTrials.gov | |
| NCT00315042 | TELI TON - Telithromycin in Tonsillitis | Phase 3 | 314 | penicillin V | Its name | ClinicalTrials.gov | |
| NCT06295120 | The Optimal Antibiotic Treatment Duration for Community-acquired Pneumonia in Adults Diagnosed in General Practice in Denmark (CAP-D) | Phase 4 | 307 | phenoxymethylpenicillin | Its name | ClinicalTrials.gov | |
| NCT04083417 | Sore Throat in Primary Care - a Comparison of Phenoxymethylpenicillin and No Antibiotic Treatment | Phase 4 | 260 | phenoxymethylpenicillin | Its name | ClinicalTrials.gov | |
| NCT00315549 | TELI TAD - Telithromycin in Tonsillitis in Adolescents and Adults | Phase 3 | 233 | penicillin V | Its name | ClinicalTrials.gov | |
| NCT01368341 | Comparing 3 Antibiotic Regimes for Erythema Migrans in General Practice | Phase 4 | 225 | phenoxymethylpenicillin | Its name | ClinicalTrials.gov | |
| NCT07549594 | Prophylaxis of Recurrent Erysipelas in Lower Limbs: compreSsion thErapy vs aNTibiotics and Compression Therapy. | Phase 4 | 200 | phenoxymethylpenicillin | Its name | ClinicalTrials.gov |
1 to 10 of 14
See all 14 trialsComparisons in its trials2
Comparisons Trial comparisons calculated in the trials whose record names the drug, most participants first. A comparison in one of its trials does not always compare the drug, so read the two groups.
| Comparison | Group 1, with the outcome | Group 2, with the outcome | Participants | Trial | Source |
|---|---|---|---|---|---|
| Penicillin Alone vs Penicillin Plus Probenecid: deaths from any cause | 0 of 20 | 0 of 20 | 40 | NCT05082909 | Trial comparisons |
| Penicillin Alone vs Penicillin Plus Probenecid: serious adverse events | 0 of 20 | 0 of 20 | 40 | NCT05082909 | Trial comparisons |
Papers from its trials8
The papers the trials whose record names the drug list on ClinicalTrials.gov as their results (RESULT) or as drawn from them (DERIVED), results first, newest first.
Tests in its trials0
The tests ConductCognition runs that the trials whose record names the drug name in their registered outcomes, as ScienceGraph matched them. ConductCognition's list names the tests it runs, not every test a trial used.
None in this release.
Data dates
The date of each source this release read.
Sources 7
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ConductCognition's list of its testsOur own data
- ClinicalTrials.govNo license stated
- NLM's MeSHNLM's terms
- Open TargetsCC0 1.0
- PubMedNLM's terms
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ConductCognition's list of its testsOur own data: ConductCognition's list of its tests, https://conductcognition.com
- ClinicalTrials.govnone stated
- NLM's MeSHNLM's
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this drug from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/drugs/v1/CHEMBL615
GET https://conductscience.org/api/drugs/v1/CHEMBL615/targets